Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Capital Expenditures: 2013-2024

Historic Capital Expenditures for Wave Life Sciences (WVE) over the last 12 years, with Dec 2024 value amounting to $938,000.

  • Wave Life Sciences' Capital Expenditures fell 35.25% to $248,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $805,000, marking a year-over-year decrease of 33.36%. This contributed to the annual value of $938,000 for FY2024, which is 15.87% down from last year.
  • According to the latest figures from FY2024, Wave Life Sciences' Capital Expenditures is $938,000, which was down 15.87% from $1.1 million recorded in FY2023.
  • Wave Life Sciences' Capital Expenditures' 5-year high stood at $1.4 million during FY2022, with a 5-year trough of $560,000 in FY2021.
  • Moreover, its 3-year median value for Capital Expenditures was $1.1 million (2023), whereas its average is $1.1 million.
  • Its Capital Expenditures has fluctuated over the past 5 years, first crashed by 65.85% in 2020, then surged by 143.04% in 2022.
  • Yearly analysis of 5 years shows Wave Life Sciences' Capital Expenditures stood at $1.3 million in 2020, then slumped by 58.15% to $560,000 in 2021, then soared by 143.04% to $1.4 million in 2022, then dropped by 18.07% to $1.1 million in 2023, then decreased by 15.87% to $938,000 in 2024.